1. Home
  2. HROW vs DAO Comparison

HROW vs DAO Comparison

Compare HROW & DAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • DAO
  • Stock Information
  • Founded
  • HROW 1998
  • DAO 2006
  • Country
  • HROW United States
  • DAO China
  • Employees
  • HROW 382
  • DAO N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • DAO Other Consumer Services
  • Sector
  • HROW Health Care
  • DAO Real Estate
  • Exchange
  • HROW Nasdaq
  • DAO Nasdaq
  • Market Cap
  • HROW 1.4B
  • DAO 1.2B
  • IPO Year
  • HROW N/A
  • DAO 2019
  • Fundamental
  • Price
  • HROW $39.22
  • DAO $8.71
  • Analyst Decision
  • HROW Strong Buy
  • DAO
  • Analyst Count
  • HROW 7
  • DAO 0
  • Target Price
  • HROW $64.67
  • DAO N/A
  • AVG Volume (30 Days)
  • HROW 671.7K
  • DAO 123.3K
  • Earning Date
  • HROW 08-11-2025
  • DAO 08-14-2025
  • Dividend Yield
  • HROW N/A
  • DAO N/A
  • EPS Growth
  • HROW N/A
  • DAO N/A
  • EPS
  • HROW N/A
  • DAO 0.27
  • Revenue
  • HROW $227,661,000.00
  • DAO $785,636,394.00
  • Revenue This Year
  • HROW $46.17
  • DAO $6.70
  • Revenue Next Year
  • HROW $39.97
  • DAO $13.94
  • P/E Ratio
  • HROW N/A
  • DAO $34.06
  • Revenue Growth
  • HROW 47.69
  • DAO N/A
  • 52 Week Low
  • HROW $20.85
  • DAO $3.00
  • 52 Week High
  • HROW $59.23
  • DAO $11.82
  • Technical
  • Relative Strength Index (RSI)
  • HROW 62.35
  • DAO 43.87
  • Support Level
  • HROW $37.09
  • DAO $8.75
  • Resistance Level
  • HROW $39.67
  • DAO $9.15
  • Average True Range (ATR)
  • HROW 2.41
  • DAO 0.38
  • MACD
  • HROW 0.10
  • DAO -0.04
  • Stochastic Oscillator
  • HROW 87.23
  • DAO 5.50

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

Share on Social Networks: